Newsbenzinga
FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated
· Published
Article summary
FDA approves GSK's Jemperli as first immunotherapy for dMMR/MSI-H rectal cancer, offering a surgery-free alternative.
An excerpt from the original article.
Comments —
Loading comments…